| Christopher Mark Begley, DO | |
|
3801 S Kanner Hwy Ste 200, Stuart, FL 34994-4801 | |
| (772) 223-4978 | |
| (772) 223-2847 |
| Full Name | Christopher Mark Begley |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 11 Years |
| Location | 3801 S Kanner Hwy Ste 200, Stuart, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306282199 | NPI | - | NPPES |
| Z2VFL | Other | FL | FLORIDA BLUE |
| 100493200 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | OS15053 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic Martin North Hospital | Stuart, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Martin Memorial Physicians Corporation Inc | 7315833555 | 372 |
News Archive
OncoGenex Pharmaceuticals, Inc., today announced that a randomized, controlled, investigator-sponsored Phase 2 clinical trial evaluating OGX-427 when administered as a monotherapy to patients with castrate resistant prostate cancer (CRPC) has received grant funding.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that it has completed dosing of its Phase 2 clinical trial of GCS-100 for the treatment of chronic kidney disease ("CKD") and has collected the final data for evaluation of the primary endpoint.
The researchers from Stanford School of Medicine and ShangaiTech University show that the growth of a coronavirus disease (COVID-19) outbreak does not behave in accordance with an exponential growth law, but instead slows down exponentially with time from the very first days. Their thought-provoking findings can be currently found in the medRxiv* preprint server.
United American Healthcare Corporation (Nasdaq: UAHC) today announced financial results for the Company's fiscal fourth quarter and full year ended June 30, 2009.
› Verified 8 days ago
| Entity Name | Martin Memorial Physicians Corporation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578505228 PECOS PAC ID: 7315833555 Enrollment ID: O20040225000440 |
News Archive
OncoGenex Pharmaceuticals, Inc., today announced that a randomized, controlled, investigator-sponsored Phase 2 clinical trial evaluating OGX-427 when administered as a monotherapy to patients with castrate resistant prostate cancer (CRPC) has received grant funding.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that it has completed dosing of its Phase 2 clinical trial of GCS-100 for the treatment of chronic kidney disease ("CKD") and has collected the final data for evaluation of the primary endpoint.
The researchers from Stanford School of Medicine and ShangaiTech University show that the growth of a coronavirus disease (COVID-19) outbreak does not behave in accordance with an exponential growth law, but instead slows down exponentially with time from the very first days. Their thought-provoking findings can be currently found in the medRxiv* preprint server.
United American Healthcare Corporation (Nasdaq: UAHC) today announced financial results for the Company's fiscal fourth quarter and full year ended June 30, 2009.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Mark Begley, DO Po Box 417, Stuart, FL 34995-0417 Ph: (772) 223-2832 | Christopher Mark Begley, DO 3801 S Kanner Hwy Ste 200, Stuart, FL 34994-4801 Ph: (772) 223-4978 |
News Archive
OncoGenex Pharmaceuticals, Inc., today announced that a randomized, controlled, investigator-sponsored Phase 2 clinical trial evaluating OGX-427 when administered as a monotherapy to patients with castrate resistant prostate cancer (CRPC) has received grant funding.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that it has completed dosing of its Phase 2 clinical trial of GCS-100 for the treatment of chronic kidney disease ("CKD") and has collected the final data for evaluation of the primary endpoint.
The researchers from Stanford School of Medicine and ShangaiTech University show that the growth of a coronavirus disease (COVID-19) outbreak does not behave in accordance with an exponential growth law, but instead slows down exponentially with time from the very first days. Their thought-provoking findings can be currently found in the medRxiv* preprint server.
United American Healthcare Corporation (Nasdaq: UAHC) today announced financial results for the Company's fiscal fourth quarter and full year ended June 30, 2009.
› Verified 8 days ago
Dr. Laura Munoz Beringer, M.D., MPH Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 614 Se Central Pkwy, Stuart, FL 34994 Phone: 772-266-0978 Fax: 772-380-4815 | |
Gaurav R Shah, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Se Osceola St, Ste 200, Stuart, FL 34994 Phone: 772-286-1550 Fax: 772-221-0569 | |
Dr. Sajith Foustin Joseph, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave # 2346, Stuart, FL 34994 Phone: 772-287-5200 | |
Dr. Ihsan Yassine, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1050 Se Monterey Rd Ste 303, Stuart, FL 34994 Phone: 772-288-2400 Fax: 772-419-0143 | |
Priya Vikash Negandhi, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave, Stuart, FL 34994 Phone: 772-223-5618 Fax: 772-288-5834 | |
Dr. Resham Khilnani, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Se Osceola St, Ste 200, Stuart, FL 34994 Phone: 772-286-1550 Fax: 772-221-0569 | |
Dr. Joseph S Gage, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Se Monterey Commons Blvd, Suite 300, Stuart, FL 34996 Phone: 772-286-9400 Fax: 772-283-3832 |